Clinical trialNCT00982436UnknownPhase 1/PHASE2Interventional

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer

SponsorUniversity of VermontEnrollment37Head and Neck Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the effectiveness and safety of neoadjuvant chemotherapy (chemotherapy given before radiotherapy) using cisplatin and docetaxel, followed by carboplatin given at the same time as radiotherapy in the treatment of locally advanced head and neck cancer.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Steven M Grunberg, MD
University of Vermont/Feltcher Allen Health Care
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mountainview Medical Center
Berlin Corners, Vermont, United States
Daniel Fram, MDDavid Ospina, MDJohn Valentine, MD
Recruiting
Fletcher Allen Health Care
Burlington, Vermont, United States
Havaleh Gagne, MDMadhuri V Vithala, MDSteven M Grunberg, MDWilliam Brundage, MD
Recruiting
Vermont Center for Cancer Medicine
Colchester, Vermont, United States
Christian Thomas, MDDennis Sanders, MDJohannes Nunnink, MDPaul Unger, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carboplatin →Docetaxel →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2009
Primary completion: 30 Sept 2012
Completion: 31 Dec 2012
Last update posted: 22 Mar 2012
Registered enrollment: 37
Registry id: NCT00982436

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.